Frankfurt - Delayed Quote EUR
Telix Pharmaceuticals Limited (T3X.F)
15.23
-0.60
(-3.79%)
As of 3:29:01 PM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1.52B
405.96M
255.35M
109.81M
Total Liabilities Net Minority Interest
948.22M
257.05M
175.35M
107.66M
Total Equity Gross Minority Interest
568.21M
148.91M
80.01M
2.16M
Total Capitalization
1.12B
157.12M
83.32M
2.16M
Common Stock Equity
568.21M
148.91M
80.01M
2.16M
Capital Lease Obligations
10.64M
8.27M
7.13M
2.52M
Net Tangible Assets
152.08M
39.25M
21.02M
-53.57M
Working Capital
587.65M
67.44M
87.68M
9.56M
Invested Capital
1.14B
158.08M
83.32M
2.18M
Tangible Book Value
152.08M
39.25M
21.02M
-53.57M
Total Debt
581.45M
17.45M
10.45M
2.54M
Share Issued
334.72M
323.73M
316.34M
285.07M
Ordinary Shares Number
334.72M
323.73M
316.34M
285.07M
12/31/2021 - 7/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OTLK Outlook Therapeutics, Inc.
1.4200
-0.70%
NUVB Nuvation Bio Inc.
2.0350
-2.63%
FOLD Amicus Therapeutics, Inc.
5.95
-3.96%
ALNY Alnylam Pharmaceuticals, Inc.
274.77
+1.84%
PTCT PTC Therapeutics, Inc.
39.80
+9.96%
ARDX Ardelyx, Inc.
3.7681
-4.61%
TGTX TG Therapeutics, Inc.
34.75
-0.32%
SRPT Sarepta Therapeutics, Inc.
37.67
-19.42%